The current collection of real‐world patients with PMF from the ERNEST‐2 registry represents the largest prospective analysis focused on cytopenic patients.
Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry
Rumi E;
2025-01-01
Abstract
The current collection of real‐world patients with PMF from the ERNEST‐2 registry represents the largest prospective analysis focused on cytopenic patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
